These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 26252502

  • 1. Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation.
    Duivenvoorden WC, Hopmans SN, Gallino D, Farrell T, Gerdes C, Glennie D, Lukka H, Pinthus JH.
    Oncol Rep; 2015 Oct; 34(4):1968-76. PubMed ID: 26252502
    [Abstract] [Full Text] [Related]

  • 2. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
    Jakubicková L, Biesová Z, Pastoreková S, Kettmann R, Pastorek J.
    Int J Oncol; 2005 Apr; 26(4):1121-7. PubMed ID: 15754010
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
    Said HM, Hagemann C, Carta F, Katzer A, Polat B, Staab A, Scozzafava A, Anacker J, Vince GH, Flentje M, Supuran CT.
    Bioorg Med Chem; 2013 Jul 01; 21(13):3949-57. PubMed ID: 23706268
    [Abstract] [Full Text] [Related]

  • 4. Generation of anti-tumour immune response using dendritic cells pulsed with carbonic anhydrase IX-Acinetobacter baumannii outer membrane protein A fusion proteins against renal cell carcinoma.
    Kim BR, Yang EK, Kim DY, Kim SH, Moon DC, Lee JH, Kim HJ, Lee JC.
    Clin Exp Immunol; 2012 Jan 01; 167(1):73-83. PubMed ID: 22132887
    [Abstract] [Full Text] [Related]

  • 5. ZEB1 transcriptionally regulated carbonic anhydrase 9 mediates the chemoresistance of tongue cancer via maintaining intracellular pH.
    Zheng G, Peng C, Jia X, Gu Y, Zhang Z, Deng Y, Wang C, Li N, Yin J, Liu X, Lu M, Tang H, He Z.
    Mol Cancer; 2015 Apr 15; 14():84. PubMed ID: 25890268
    [Abstract] [Full Text] [Related]

  • 6. Carbonic anhydrase 9 (CA9) expression in tumor cells enhances sensitivity to tirapazamine.
    Shin HJ, Kim JY, Yoo CW, Roberts SA, Lee S, Choi SJ, Lee HY, Lee DH, Kim TH, Cho KH.
    J Cancer Res Clin Oncol; 2008 Mar 15; 134(3):397-404. PubMed ID: 17724612
    [Abstract] [Full Text] [Related]

  • 7. Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells.
    Parks SK, Cormerais Y, Durivault J, Pouyssegur J.
    Oncotarget; 2017 Feb 07; 8(6):10225-10237. PubMed ID: 28055960
    [Abstract] [Full Text] [Related]

  • 8. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT, Tu JJ, Kao J, Zhou XK, Mazumdar M.
    Clin Cancer Res; 2005 Sep 15; 11(18):6558-66. PubMed ID: 16166433
    [Abstract] [Full Text] [Related]

  • 9. Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT.
    Lawrentschuk N, Lee FT, Jones G, Rigopoulos A, Mountain A, O'Keefe G, Papenfuss AT, Bolton DM, Davis ID, Scott AM.
    Urol Oncol; 2011 Sep 15; 29(4):411-20. PubMed ID: 19523858
    [Abstract] [Full Text] [Related]

  • 10. Sulfonamide derivative targeting carbonic anhydrase IX as a nuclear imaging probe for colorectal cancer detection in vivo.
    Guan SS, Cheng CC, Ho AS, Wang CC, Luo TY, Liao TZ, Chang J, Wu CT, Liu SH.
    Oncotarget; 2015 Nov 03; 6(34):36139-55. PubMed ID: 26447758
    [Abstract] [Full Text] [Related]

  • 11. CA9 gene expression in conventional renal cell carcinoma: a potential marker for prediction of early metastasis after nephrectomy.
    Li G, Feng G, Gentil-Perret A, Genin C, Tostain J.
    Clin Exp Metastasis; 2007 Nov 03; 24(3):149-55. PubMed ID: 17390110
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapy.
    Gigante M, Li G, Ferlay C, Perol D, Blanc E, Paul S, Zhao A, Tostain J, Escudier B, Negrier S, Genin C.
    Anticancer Res; 2012 Dec 03; 32(12):5447-51. PubMed ID: 23225450
    [Abstract] [Full Text] [Related]

  • 13. [The role of MN/CA IX antigen in carcinogenesis and metastasis of renal cell carcinoma].
    Nakagawa Y, Uemura H, Shimizu K, Cho M, Yoshikawa M, Hirao Y, Yoshikawa K.
    Hinyokika Kiyo; 2001 Nov 03; 47(11):809-14. PubMed ID: 11771176
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma.
    Todenhöfer T, Gibb EA, Seiler R, Kamyabi A, Hennenlotter J, McDonald P, Moskalev I, Stewart C, Gao J, Fazli L, Dedhar S, Stenzl A, Oo HZ, Black PC.
    Urol Oncol; 2021 Aug 03; 39(8):498.e1-498.e11. PubMed ID: 34083096
    [Abstract] [Full Text] [Related]

  • 15. The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors.
    Cetin B, Gonul II, Buyukberber S, Afsar B, Gumusay O, Algın E, Turan N, Ozet A, Benekli M, Coskun U.
    Tumour Biol; 2015 Nov 03; 36(11):8471-8. PubMed ID: 26026587
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detection of circulating MN/CA9 positive renal cell carcinoma cells during operation.
    Uemura H, Nakagawa Y, Iwai A, Okajima E, Okajima E, Yoshikawa K, Hirao Y.
    Aktuelle Urol; 2003 Jul 03; 34(4):270-2. PubMed ID: 14566683
    [Abstract] [Full Text] [Related]

  • 18. Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment.
    Perut F, Carta F, Bonuccelli G, Grisendi G, Di Pompo G, Avnet S, Sbrana FV, Hosogi S, Dominici M, Kusuzaki K, Supuran CT, Baldini N.
    Expert Opin Ther Targets; 2015 Jul 03; 19(12):1593-605. PubMed ID: 26357839
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation.
    Yun EJ, Lin CJ, Dang A, Hernandez E, Guo J, Chen WM, Allison J, Kim N, Kapur P, Brugarolas J, Wu K, He D, Lai CH, Lin H, Saha D, Baek ST, Chen BPC, Hsieh JT.
    Clin Cancer Res; 2019 Jul 15; 25(14):4542-4551. PubMed ID: 31000589
    [Abstract] [Full Text] [Related]

  • 20. [MN/CA IX antigen as a potential target for renal cell carcinoma].
    Uemura H, Cho M, Nakagawa Y, Shimizu K, Yoshikawa M, Kim S, Hirao Y.
    Hinyokika Kiyo; 2000 Oct 15; 46(10):745-8. PubMed ID: 11215204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.